US Broker Ratings

Becton, Dickinson and Company (BDX): Investor Outlook on a Healthcare Giant with a 4.38% Upside

Becton, Dickinson and Company (NYSE: BDX) stands as a colossus in the healthcare sector, specializing in medical instruments and supplies, with a sprawling portfolio that caters to healthcare institutions, life..

Haleon plc (HLN) Stock Analysis: Exploring a Potential 20% Upside for Investors in the Healthcare Sector

Haleon plc (HLN), a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, captures the spotlight with an intriguing investment opportunity. With a market..

Qiagen N.V. (QGEN) Stock Analysis: A 14.59% Potential Upside in the Healthcare Sector

Qiagen N.V. (QGEN) is making waves in the healthcare sector with its innovative approach to diagnostics and research. Headquartered in Venlo, Netherlands, Qiagen specializes in providing sample-to-insight solutions, transforming biological..

Humana Inc. (HUM) Stock Analysis: Exploring a 21.65% Upside Potential Amidst Healthcare Growth

Humana Inc. (NYSE: HUM) stands as a formidable player in the healthcare plans industry, boasting a market capitalization of $28.52 billion. As a pivotal entity within the healthcare sector, Humana..

McKesson Corporation (MCK) Stock Analysis: A Defensive Play with Growth Potential and a 10.36% Upside

McKesson Corporation (NYSE: MCK), a stalwart in the healthcare sector, is an intriguing proposition for investors seeking both stability and growth potential. With a market capitalization of $104.45 billion, McKesson..

Alcon Inc. (ALC) Stock Analysis: Eyeing a 22.64% Upside in Healthcare Innovation

Alcon Inc. (NYSE: ALC), a prominent player in the medical instruments and supplies sector, is capturing investor attention with a robust market cap of $38.71 billion and a promising potential..

ICON plc (ICLR) Stock Analysis: Evaluating a 27% Upside Potential in the Healthcare Sector

Investors interested in the healthcare sector may find ICON plc (NASDAQ: ICLR) an intriguing prospect. This Dublin-based clinical research organization, with a market cap of $12.48 billion, is strategically positioned..

Koninklijke Philips N.V. (PHG) Stock Analysis: Exploring the 17.98% Upside Potential

Koninklijke Philips N.V. (PHG), a stalwart in the healthcare sector, continues to draw investor attention with its promising upside potential of 17.98%. Operating as a health technology company with a..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Navigating a 9% Potential Upside Amidst Healthcare Innovations

Teva Pharmaceutical Industries Limited (TEVA), a key player in the global pharmaceutical landscape, is drawing significant attention from investors. This Israel-based healthcare giant, known for its expansive portfolio of generic..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: A 7.62% Potential Upside in the Biotech Sector

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) continues to capture significant attention within the biotechnology sector, driven by its innovative approach and robust pipeline. With a market capitalization nearing $60 billion, Alnylam..

Genmab A/S (GMAB) Stock Analysis: A Promising 23% Potential Upside in the Biotech Sector

Genmab A/S (GMAB), a leading player in the biotechnology sector based in Denmark, is attracting attention from investors with its robust growth potential and strategic collaborations. With a current market..

Bristol-Myers Squibb (BMY) Investor Outlook: Exploring a 13% Potential Upside Amid Strong Dividend Yield

Bristol-Myers Squibb Company (NYSE: BMY), a prominent player in the healthcare sector, operates at the forefront of the biopharmaceutical industry. With a market capitalization of $99 billion, the company continues..

Veeva Systems Inc. (VEEV) Stock Analysis: A Promising 9.24% Upside for Healthcare Tech Investors

Investors in Veeva Systems Inc. (NYSE: VEEV) have much to consider as the company continues to carve out a significant niche in the healthcare technology sector. With its cloud-based solutions..

Insmed Incorporated (INSM) Stock Analysis: Exploring the High Potential in Rare Disease Treatments with an Upside of Nearly 8%

Insmed Incorporated (NASDAQ: INSM), a prominent player in the biotechnology sector, is making waves with its robust development pipeline targeting serious and rare diseases. With a market capitalization of $41.21..

Centene Corporation (CNC) Stock Analysis: Navigating a 21.5% Revenue Growth Amidst Healthcare Sector Challenges

Centene Corporation (NYSE: CNC) stands as a significant player in the healthcare sector, specifically within the healthcare plans industry. With a market capitalization of $17.88 billion, Centene has established itself..

Incyte Corporation (INCY) Stock Analysis: A Healthcare Powerhouse with Robust Revenue Growth

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology sector, continues to capture investor attention with its impressive revenue growth and extensive range of therapeutics. The company’s market capitalization..

Mettler-Toledo International, Inc. (MTD) Stock Analysis: Is There a 6.38% Upside Waiting for Investors?

Mettler-Toledo International, Inc. (NYSE: MTD) is a heavyweight in the healthcare sector, specifically in the diagnostics and research industry. With a current market capitalization of $28.85 billion, Mettler-Toledo is a..

Natera, Inc. (NTRA) Stock Analysis: A Healthcare Innovator with 13% Upside Potential

Natera, Inc. (NASDAQ: NTRA) stands as a prominent player in the diagnostics and research industry within the healthcare sector. With a market capitalization of $28.19 billion, Natera’s innovative molecular testing..

Fresenius Medical Care AG (FMS) Stock Analysis: Exploring a 25% Potential Upside in the Healthcare Sector

Fresenius Medical Care AG (NYSE: FMS), a global leader in providing dialysis services and products, presents a compelling case for investors looking to capitalize on opportunities within the healthcare sector...

Biogen Inc. (BIIB) Stock Analysis: Evaluating the 5.11% Potential Upside for Investors

Biogen Inc. (NASDAQ: BIIB) stands as a prominent player in the healthcare sector, particularly within the drug manufacturing industry, with a concentrated focus on neurological and neurodegenerative diseases. With a..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds